NCT02991469 A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS) Status RECRUITING Phase PHASE2
NCT02984982 Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia Status COMPLETED Phase PHASE4
NCT02979015 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT02958436 A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02957682 Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo Status COMPLETED Phase PHASE4
NCT02948959 Evaluation of Dupilumab in Children With Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT02943239 Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men Status COMPLETED Phase PHASE1
NCT02924311 Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema Status COMPLETED Phase N/A
NCT02912468 A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps Status COMPLETED Phase PHASE3
NCT02898454 Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Status COMPLETED Phase PHASE3
NCT02890992 An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT02870400 A Study to Examine the Safety and Tolerability of Single Ascending Doses of REGN2477 Status COMPLETED Phase PHASE1
NCT02863354 Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE2
NCT02828397 Study of the Blood Concentrations of Two Formulations of REGN2222 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02828033 Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss Status UNKNOWN Phase EARLY_PHASE1
NCT02777151 Study of Safety, Tolerability, and Pharmacokinetics of REGN3470-3471-3479 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1